HLA Typing for Transplant Market is estimated to increase at a Compounded Annual Growth Rate of 8.1% CAGR over the forecast period from 2024 to 2030
The HLA Typing for Transplant Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Products and Services (Reagents & Consumables, Instruments, Software & Services), By Technology (Molecular Assay Technologies, Non-molecular Assay Technologies), By Application (Diagnostic Applications, Research Applications), By Transplant (Solid Organ Transplant, Soft Tissue Transplant), By End-User (Independent Reference Laboratories, Hospitals & Transplant Centers, Research Laboratories & Academic Institutes).
An Introduction to HLA Typing for Transplant Market in 2024
HLA typing plays a critical role in organ transplantation by determining the compatibility between donors and recipients, thereby minimizing the risk of rejection and improving transplant outcomes. In 2024, advancements in HLA typing technologies have led to greater accuracy, efficiency, and accessibility in identifying human leukocyte antigen (HLA) alleles. Next-generation sequencing (NGS) techniques have emerged as the gold standard, offering high-resolution typing and comprehensive allele coverage. Additionally, novel bioinformatics tools enable rapid analysis and interpretation of HLA sequencing data, facilitating personalized transplant matching and reducing the likelihood of post-transplant complications. As demand for organ transplants continues to rise, the continued refinement of HLA typing methodologies is essential for optimizing donor-recipient compatibility and improving patient survival rates.
Market Trend: Increasing Demand for Transplant Procedures
A prominent trend in the HLA typing for transplant market is the increasing demand for transplant procedures. With advancements in transplantation techniques and regenerative medicine, there is a growing acceptance and adoption of organ and tissue transplantation as viable treatment options for various diseases and conditions. HLA typing plays a crucial role in transplant compatibility assessment by matching the human leukocyte antigen (HLA) profiles of donors and recipients to minimize the risk of rejection and improve transplant outcomes. This trend reflects the rising need for accurate and comprehensive HLA typing services to support the increasing number of transplant surgeries performed worldwide, driving market growth and investment in HLA typing technologies.
Market Driver: Rising Incidence of End-Stage Organ Failure
A primary driver fueling the growth of the HLA typing for transplant market is the rising incidence of end-stage organ failure. Chronic diseases such as chronic kidney disease, liver cirrhosis, and heart failure continue to affect millions of people globally, leading to end-stage organ failure and the need for transplant interventions. HLA typing is essential in identifying suitable organ donors and recipients, ensuring compatibility and reducing the risk of transplant rejection. As the prevalence of end-stage organ failure increases due to factors such as aging populations, lifestyle-related diseases, and advancements in medical care that prolong life expectancy, there is a growing demand for HLA typing services to facilitate successful transplant surgeries, driving market expansion and adoption of HLA typing technologies.
Market Opportunity: Expansion into Next-Generation Sequencing (NGS) HLA Typing
An enticing opportunity within the HLA typing for transplant market lies in the expansion into next-generation sequencing (NGS) technologies. NGS-based HLA typing offers advantages such as high throughput, accuracy, and comprehensive HLA allele resolution compared to traditional methods such as sequence-specific oligonucleotide (SSO) typing and sequence-based typing (SBT). By leveraging NGS platforms for HLA typing, laboratories can perform rapid and cost-effective HLA allele typing, allele-level resolution, and identification of rare and novel HLA alleles, enhancing transplant matching accuracy and patient outcomes. Furthermore, NGS-based HLA typing enables the simultaneous detection of other relevant genetic variants associated with transplant outcomes, such as donor-recipient compatibility and immune response genes. By investing in NGS-based HLA typing technologies, companies can capitalize on the growing demand for advanced transplant diagnostics and position themselves as leaders in the competitive HLA typing market, thereby driving innovation and growth in the field of transplant medicine.
HLA Typing for Transplant Market Share Analysis: Molecular Assay Technologies - Sequencing-based Molecular Assays is the fastest growing segment over the forecast period to 2030
In the HLA Typing for Transplant Market, the segment experiencing the most rapid growth is Sequencing-based Molecular Assays within the Molecular Assay Technologies category. This growth is propelled by several key factors. Firstly, sequencing-based molecular assays offer unparalleled resolution and accuracy in human leukocyte antigen (HLA) typing, allowing for precise identification of genetic variations within the HLA genes. These assays utilize next-generation sequencing (NGS) technology to sequence the entire HLA gene region, enabling comprehensive characterization of HLA alleles and subtypes. This level of detail is essential for matching donors and recipients in organ and tissue transplantation, where HLA compatibility significantly influences transplant outcomes and graft survival. Secondly, sequencing-based molecular assays offer multiplexing capabilities, allowing for simultaneous analysis of multiple HLA loci and alleles in a single assay. This multiplexing approach increases throughput and efficiency, reducing turnaround times and enabling high-volume HLA typing for transplant programs with large donor and recipient pools. Thirdly, advancements in sequencing technology, bioinformatics, and data analysis have improved the speed, sensitivity, and cost-effectiveness of sequencing-based HLA typing assays. These technological innovations have democratized access to high-resolution HLA typing, making it more accessible to transplant centers, reference laboratories, and research institutions worldwide. Moreover, sequencing-based molecular assays have broader applications beyond transplantation, including disease association studies, pharmacogenomics, and population genetics research, further driving their adoption and market growth. As a result, Sequencing-based Molecular Assays emerge as the fastest growing segment in the HLA Typing for Transplant Market, offering unparalleled accuracy, multiplexing capabilities, and scalability for HLA typing in transplantation and research applications.
HLA Typing for Transplant Competitive Analysis
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossBio-Rad Laboratories Inc, CareDx Inc, F. Hoffmann-La Roche Ltd, Illumina Inc, Immucor, Inc, Luminex Corp, QIAGEN N.V., Thermo Fisher Scientific Inc
HLA Typing for Transplant Market Segmentation
By Products and Services
Reagents & Consumables
Instruments
Software & Services
By Technology
Molecular Assay Technologies
-PCR-Based Molecular Assays
-Sequencing-based Molecular Assays
Non-molecular Assay Technologies
By Application
Diagnostic Applications
-Antibody Screening
-Chimerism Monitoring
-Others
Research Applications
By Transplant
Solid Organ Transplant
Soft Tissue Transplant
By End-User
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
HLA Typing for Transplant Market Companies
Bio-Rad Laboratories Inc
CareDx Inc
F. Hoffmann-La Roche Ltd
Illumina Inc
Immucor, Inc
Luminex Corp
QIAGEN N.V.
Thermo Fisher Scientific Inc
Reasons to Buy the HLA Typing for Transplant Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the HLA Typing for Transplant Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the HLA Typing for Transplant Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 HLA Typing for Transplant Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global HLA Typing for Transplant Market Size Outlook, $ Million, 2021 to 2030
3.2 HLA Typing for Transplant Market Outlook by Type, $ Million, 2021 to 2030
3.3 HLA Typing for Transplant Market Outlook by Product, $ Million, 2021 to 2030
3.4 HLA Typing for Transplant Market Outlook by Application, $ Million, 2021 to 2030
3.5 HLA Typing for Transplant Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of HLA Typing for Transplant Industry
4.2 Key Market Trends in HLA Typing for Transplant Industry
4.3 Potential Opportunities in HLA Typing for Transplant Industry
4.4 Key Challenges in HLA Typing for Transplant Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global HLA Typing for Transplant Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global HLA Typing for Transplant Market Outlook by Segments
7.1 HLA Typing for Transplant Market Outlook by Segments, $ Million, 2021- 2030
By Products and Services
Reagents & Consumables
Instruments
Software & Services
By Technology
Molecular Assay Technologies
-PCR-Based Molecular Assays
-Sequencing-based Molecular Assays
Non-molecular Assay Technologies
By Application
Diagnostic Applications
-Antibody Screening
-Chimerism Monitoring
-Others
Research Applications
By Transplant
Solid Organ Transplant
Soft Tissue Transplant
By End-User
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
8 North America HLA Typing for Transplant Market Analysis and Outlook To 2030
8.1 Introduction to North America HLA Typing for Transplant Markets in 2024
8.2 North America HLA Typing for Transplant Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America HLA Typing for Transplant Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents & Consumables
Instruments
Software & Services
By Technology
Molecular Assay Technologies
-PCR-Based Molecular Assays
-Sequencing-based Molecular Assays
Non-molecular Assay Technologies
By Application
Diagnostic Applications
-Antibody Screening
-Chimerism Monitoring
-Others
Research Applications
By Transplant
Solid Organ Transplant
Soft Tissue Transplant
By End-User
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
9 Europe HLA Typing for Transplant Market Analysis and Outlook To 2030
9.1 Introduction to Europe HLA Typing for Transplant Markets in 2024
9.2 Europe HLA Typing for Transplant Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe HLA Typing for Transplant Market Size Outlook by Segments, 2021-2030
By Products and Services
Reagents & Consumables
Instruments
Software & Services
By Technology
Molecular Assay Technologies
-PCR-Based Molecular Assays
-Sequencing-based Molecular Assays
Non-molecular Assay Technologies
By Application
Diagnostic Applications
-Antibody Screening
-Chimerism Monitoring
-Others
Research Applications
By Transplant
Solid Organ Transplant
Soft Tissue Transplant
By End-User
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
10 Asia Pacific HLA Typing for Transplant Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific HLA Typing for Transplant Markets in 2024
10.2 Asia Pacific HLA Typing for Transplant Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific HLA Typing for Transplant Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents & Consumables
Instruments
Software & Services
By Technology
Molecular Assay Technologies
-PCR-Based Molecular Assays
-Sequencing-based Molecular Assays
Non-molecular Assay Technologies
By Application
Diagnostic Applications
-Antibody Screening
-Chimerism Monitoring
-Others
Research Applications
By Transplant
Solid Organ Transplant
Soft Tissue Transplant
By End-User
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
11 South America HLA Typing for Transplant Market Analysis and Outlook To 2030
11.1 Introduction to South America HLA Typing for Transplant Markets in 2024
11.2 South America HLA Typing for Transplant Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America HLA Typing for Transplant Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents & Consumables
Instruments
Software & Services
By Technology
Molecular Assay Technologies
-PCR-Based Molecular Assays
-Sequencing-based Molecular Assays
Non-molecular Assay Technologies
By Application
Diagnostic Applications
-Antibody Screening
-Chimerism Monitoring
-Others
Research Applications
By Transplant
Solid Organ Transplant
Soft Tissue Transplant
By End-User
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
12 Middle East and Africa HLA Typing for Transplant Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa HLA Typing for Transplant Markets in 2024
12.2 Middle East and Africa HLA Typing for Transplant Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa HLA Typing for Transplant Market size Outlook by Segments, 2021-2030
By Products and Services
Reagents & Consumables
Instruments
Software & Services
By Technology
Molecular Assay Technologies
-PCR-Based Molecular Assays
-Sequencing-based Molecular Assays
Non-molecular Assay Technologies
By Application
Diagnostic Applications
-Antibody Screening
-Chimerism Monitoring
-Others
Research Applications
By Transplant
Solid Organ Transplant
Soft Tissue Transplant
By End-User
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Bio-Rad Laboratories Inc
CareDx Inc
F. Hoffmann-La Roche Ltd
Illumina Inc
Immucor, Inc
Luminex Corp
QIAGEN N.V.
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Products and Services
Reagents & Consumables
Instruments
Software & Services
By Technology
Molecular Assay Technologies
-PCR-Based Molecular Assays
-Sequencing-based Molecular Assays
Non-molecular Assay Technologies
By Application
Diagnostic Applications
-Antibody Screening
-Chimerism Monitoring
-Others
Research Applications
By Transplant
Solid Organ Transplant
Soft Tissue Transplant
By End-User
Independent Reference Laboratories
Hospitals & Transplant Centers
Research Laboratories & Academic Institutes
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
